The Safety of Stroke Mimics

In terms of symptomatic hemorrhage which is what we are most concerned about between alti-plays and dual anti-platelet there was essentially no difference. In RAMIS unfortunately we didn't have a special section for the mimic patients because most of patients were already confirmed by imaging. So to what degree patients had either modality I would have to dissect in the the details of the protocol but suffice to say that in real world you're not necessarily going to know if you're going to be treating a mimic upfront unless it's obvious or they have other medical history like a prior migraine that's complex.